Drug Pipeline

Rotarix Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
2
Phase 3
2
Top Sponsors
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-06-04 NCT07626606 How Gut Health Affects Immune Responses to the Oral Rotavirus Vaccine in Adults in Zambia Recruiting
Active Studies by Phase
Phase 3
2
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06824181 Study of Mixed Vaccination Schedules With a 21-valent Pneumococcal Conjugate Vaccine and… Pneumococcal Immunization Active, Not Recruiting
NCT06824194 Study of the Safety of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From… Pneumococcal Immunization Active, Not Recruiting
Not specified
NCT07626606 How Gut Health Affects Immune Responses to the Oral Rotavirus Vaccine in Adults in Zambia Feasibility Study Recruiting
Sponsors Running Rotarix Trials
Sanofi (2) Centre for Infectious Disease Research in Zambia (1)
Get alerts when Rotarix trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free